Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Plasma levels of macrophage inflammatory protein-1 (MIP-1) (A), macrophage inflammatory protein-1ß (MIP-1ß) (B) and interleukin-8 (IL-8) (C), given as the percent change from baseline (MIP-1: 25.2 ± 2.0 pg/ml; MIP-1ß: 93.4 ± 4.5 pg/ml; IL-8: 22.8 ± 1.8 pg/ml), in 20 patients with chronic heart failure before and at different time points after initiating treatment with intravenous immunoglobulin (n = 10; solid circles) or placebo (n = 10; open circles). Data are given as the mean value ± SEM. *p < 0.05; **p < 0.01 versus baseline; #p < 0.05 when comparing changes between intravenous immunoglobulin and placebo.
|
